Note: The headline of this article was updated Feb. 27, 2023, to better reflect that Veletri is considered a safe…
Lindsey Shapiro, PhD
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lindsey Shapiro, PhD
People with pulmonary hypertension (PH) who had elevated blood levels of the trimethylamine N-oxide (TMAO) molecule were at a…
Dosing is complete in a Phase 1 clinical trial of AER-901, Aerami Therapeutics’ inhaled formulation of imatinib that’s being…
Researchers have created an automated way to engineer a more stable peptide-based therapy, which could inform the production of new…
Real-world use of Opsumit (macitentan) was generally safe, with few liver-related toxicities seen, according to data from two registries largely…
A rare mutation in the GDF2 gene was identified in two siblings, a boy and a girl, with pulmonary arterial hypertension…
People with pulmonary arterial hypertension (PAH) are at a higher risk of acute heart failure when admitted to the…
Digital health company Eko has been awarded $2.7 million from the National Institutes of Health (NIH) to develop an artificial…
The Mayo Clinic will use a digital clinical trial platform developed by Triall in an upcoming pulmonary…
Measuring blood levels of a certain type of DNA released by damaged cells — called cell-free DNA — may be…
Blood levels of IL-6 and PTX3 — two inflammatory proteins — could serve as prognostic biomarkers in people with…
Nearly a third (29.7%) of COVID-19 patients showed signs of pulmonary hypertension (PH) on an echocardiogram — a scan…